INTRODUCTION
Background 3 a. Include sufficient scientific background (including relevant references to previous work) to understand the motivation and context for the study, and explain the experimental approach and rationale. b. Explain how and why the animal species and model being used can address the scientific objectives and, where appropriate, the study's relevance to human biology.
Objectives 4 Clearly describe the primary and any secondary objectives of the study, or specific hypotheses being tested. b. If any animals or data were not included in the analysis, explain why.
METHODS

Ethical statement
Outcomes and estimation
16
Report the results for each analysis carried out, with a measure of precision (e.g. standard error or confidence interval).
Adverse events 17 a. Give details of all important adverse events in each experimental group. b. Describe any modifications to the experimental protocols made to reduce adverse events. c. Describe any implications of your experimental methods or findings for the replacement, refinement or reduction (the 3Rs) of the use of animals in research.
Generalisability/ translation
19 Comment on whether, and how, the findings of this study are likely to translate to other species or systems, including any relevance to human biology.
Funding 20 List all funding sources (including grant number) and the role of the funder(s) in the study. 9. a. Animals were located in the vivarium with controlled airflow, temperature (72±2C ), and humidity (50±5%); Animals were group housed (maximum 5 mice per cage) in the sterile cages of the Tecniplast Greenline rodent caging system. Mice were provided enrichment devices such as polycarbonate shelters, tunnels or huts, as well as Nylabones and wood blocks. The processed corncob product was used for bedding material.
b.
Animal room lighting is set with a diurnal cycle (light on at 6 pm and off at 6 pm). Animal feed used: Irradiated Low Isoflavone 5V02 IF50 Purina Chow; animal access to food and water ad libitum.
c.
General conditions of study animals were checked daily, and tumor growth was monitored twice weekly. Animals with health conditions were removed from studies and euthanized following an IACUC approved animal use protocol.
10.
a. Described in study results (n=7-10 per group) b.
Based on our historical data, the number of animals was determined so that statistical power to detect a 50% tumor reduction is >80% using the Anova P analysis c. NA 11. a. Animals were randomized into treatment groups weighted on the tumor size.
b. Doses were given in the order of treatment groups the animals assigned on.
12.
Efficacy of ADC in mouse tumor xenograft model by monitoring tumor sizes. More details in Results.
